메뉴 건너뛰기




Volumn 5, Issue 6, 2016, Pages 539-549

Comparative effectiveness of adalimumab and etanercept for rheumatoid arthritis in the Brazilian Public Health System

Author keywords

adalimumab; Brazil; cohort study; effectiveness; etanercept; rheumatoid arthritis

Indexed keywords

ADALIMUMAB; CORTICOSTEROID DERIVATIVE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; INFLIXIMAB; MONOCLONAL ANTIBODY;

EID: 84992154422     PISSN: 20426305     EISSN: 20426313     Source Type: Journal    
DOI: 10.2217/cer-2016-0027     Document Type: Article
Times cited : (12)

References (56)
  • 1
    • 0035883897 scopus 로고    scopus 로고
    • Rheumatoid arthritis
    • Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 358(9285), 903-911 (2001).
    • (2001) Lancet , vol.358 , Issue.9285 , pp. 903-911
    • Lee, D.M.1    Weinblatt, M.E.2
  • 3
    • 84905647565 scopus 로고    scopus 로고
    • Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: A synopsis
    • Gibofsky A. Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis. Am. J. Manag. Care. 20(7. Suppl.), S128-S135 (2014).
    • (2014) Am. J. Manag. Care. , vol.20 , Issue.7 , pp. S128-S135
    • Gibofsky, A.1
  • 5
    • 1542724885 scopus 로고    scopus 로고
    • Prevalence of rheumatic diseases in Brazil: A study using the COPCORD approach
    • Senna ER, De Barros AL, Silva EO et al. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J. Rheumatol. 31, 594-597 (2004).
    • (2004) J. Rheumatol. , vol.31 , pp. 594-597
    • Senna, E.R.1    De Barros, A.L.2    Silva, E.O.3
  • 6
    • 84859309049 scopus 로고    scopus 로고
    • 2012 Brazilian society of rheumatology consensus for the treatment of rheumatoid arthritis
    • da Mota LM, Cruz BA, Brenol CV et al. 2012 Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis. Rev. Bras. Reumatol. 52, 152-174 (2012).
    • (2012) Rev. Bras. Reumatol. , vol.52 , pp. 152-174
    • Da Mota, L.M.1    Cruz, B.A.2    Brenol, C.V.3
  • 7
    • 77953696525 scopus 로고    scopus 로고
    • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
    • Smolen JS, Landewé R, Breedveld FC et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann. Rheum. 69, 964-975 (2010).
    • (2010) Ann. Rheum. , vol.69 , pp. 964-975
    • Smolen, J.S.1    Landewé, R.2    Breedveld, F.C.3
  • 8
    • 84859832981 scopus 로고    scopus 로고
    • 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
    • Singh JA, Furst DE, Bharat A et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res. 64, 625-639 (2012).
    • (2012) Arthritis Care Res. , vol.64 , pp. 625-639
    • Singh, J.A.1    Furst, D.E.2    Bharat, A.3
  • 9
    • 80054980301 scopus 로고
    • Constituição da República Fedeativa do Brasil. Brasil
    • BRASIL. Senado Federal. Constituição da República Fedeativa do Brasil. Brasil (1988). www.planalto.gov.br/ccivil-03
    • (1988) Senado Federal
    • BRASIL1
  • 11
    • 33847588216 scopus 로고    scopus 로고
    • Secretaria de Atenção à Saúde. Portaria n. 865, de 25 de novembro de 2002. Aprova o Protocolo Clínico e Diretrizes Terapêuticas da Artrite Reumatoide. Brasil
    • BRASIL. Ministério da Saúde. Secretaria de Atenção à Saúde. Portaria n. 865, de 25 de novembro de 2002. Aprova o Protocolo Clínico e Diretrizes Terapêuticas da Artrite Reumatoide. Brasil (2002). www.saudedireta.com.br/docsupload
    • (2002) Ministério da Saúde
    • BRASIL1
  • 12
    • 33847588216 scopus 로고    scopus 로고
    • Secretaria de Atenção à Saúde. Portaria n. 66, de 1 de novembro de 2006. Aprova o Protocolo Clínico e Diretrizes Terapêuticas da Artrite Reumatoide. Brasil
    • BRASIL. Ministério da Saúde. Secretaria de Atenção à Saúde. Portaria n. 66, de 1 de novembro de 2006. Aprova o Protocolo Clínico e Diretrizes Terapêuticas da Artrite Reumatoide. Brasil (2006). http://bvsms.saude.gov.br/bvs/saudelegis
    • (2006) Ministério da Saúde
    • BRASIL1
  • 13
    • 84962495978 scopus 로고    scopus 로고
    • Implementation of clinical guidelines in Brazil: Should academic detailing be used?
    • Costa JO, Almeida-Brasil CC, Godman B et al. Implementation of clinical guidelines in Brazil: should academic detailing be used? J. Pharm. Health Services Res. 7(2), 105-115 (2016).
    • (2016) J. Pharm. Health Services Res. , vol.7 , Issue.2 , pp. 105-115
    • Costa, J.O.1    Almeida-Brasil, C.C.2    Godman, B.3
  • 14
    • 33847588216 scopus 로고    scopus 로고
    • Departamento de Informática do SUS - DATASUS. Informações em saúde (TABNET). Assistência a Saúde. Produção ambulatorial. DATASUS
    • BRASIL. Ministério da Saúde. Departamento de Informática do SUS - DATASUS. Informações em saúde (TABNET). Assistência a Saúde. Produção ambulatorial. DATASUS, 2016. www2.datasus.gov.br/DATASUS
    • (2016) Ministério da Saúde
    • BRASIL1
  • 15
    • 33644804877 scopus 로고    scopus 로고
    • The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): A review of their usefulness and validity in rheumatoid arthritis
    • Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin. Exp. Rheumatol. 23(Suppl. 39), S100-S108 (2005).
    • (2005) Clin. Exp. Rheumatol. , vol.23 , pp. S100-S108
    • Aletaha, D.1    Smolen, J.2
  • 16
    • 0037229712 scopus 로고    scopus 로고
    • The stanford health assessment questionnaire: A review of its history, issues, progress, and documentation
    • Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J. Rheumatol. 30, 100-108 (2003).
    • (2003) J. Rheumatol. , vol.30 , pp. 100-108
    • Bruce, B.1    Fries, J.F.2
  • 17
    • 0025688231 scopus 로고
    • EuroQol - A new facility for the measurement of health-related quality of life
    • EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Pol. 16, 199-208 (1990).
    • (1990) Health Pol. , vol.16 , pp. 199-208
  • 18
    • 84952909836 scopus 로고    scopus 로고
    • Brazilian valuation of EQ-5D-3L health states: Results from a saturation study
    • Santos M, Cintra MA, Monteiro AL et al. Brazilian valuation of EQ-5D-3L health states: results from a saturation study. Med. Decis. Making 36(2), 253-263 (2015).
    • (2015) Med. Decis. Making , vol.36 , Issue.2 , pp. 253-263
    • Santos, M.1    Cintra, M.A.2    Monteiro, A.L.3
  • 20
    • 33846079219 scopus 로고    scopus 로고
    • The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: A systematic review and metaanalysis
    • Gartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN. The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. J. Rheumatol. 33, 2398-2408 (2006).
    • (2006) J. Rheumatol. , vol.33 , pp. 2398-2408
    • Gartlehner, G.1    Hansen, R.A.2    Jonas, B.L.3    Thieda, P.4    Lohr, K.N.5
  • 21
    • 0142156483 scopus 로고    scopus 로고
    • Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis
    • Hochberg MC, Tracy JK, Hawkins-Holt M, Flores RH. Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis. Ann. Rheum. Dis. 62(Suppl. 2), ii13-ii16 (2003).
    • (2003) Ann. Rheum. Dis. , vol.62 , pp. ii13-ii16
    • Hochberg, M.C.1    Tracy, J.K.2    Hawkins-Holt, M.3    Flores, R.H.4
  • 22
    • 38749141455 scopus 로고    scopus 로고
    • Systematic review: Comparative effectiveness and harms of diseasemodifying medications for rheumatoid arthritis
    • Donahue KE, Gartlehner G, Jonas DE et al. Systematic review: comparative effectiveness and harms of diseasemodifying medications for rheumatoid arthritis. Ann. Intern. Med. 148, 124-134 (2008).
    • (2008) Ann. Intern. Med. , vol.148 , pp. 124-134
    • Donahue, K.E.1    Gartlehner, G.2    Jonas, D.E.3
  • 23
    • 84992030477 scopus 로고    scopus 로고
    • What is the best biological for arthritis rheumatoid? A systematic review of effectiveness
    • Dos Santos JB, Costa JO, Oliveira Junior HA et al. What is the best biological for arthritis rheumatoid? A systematic review of effectiveness. World J. Rheumatol. 5(2), 108-126 (2015).
    • (2015) World J. Rheumatol. , vol.5 , Issue.2 , pp. 108-126
    • Dos Santos, J.B.1    Costa, J.O.2    Oliveira Junior, H.A.3
  • 24
    • 84944811040 scopus 로고    scopus 로고
    • Comparing effects of biologic agents in treating patients with rheumatoid arthritis: A multiple treatment comparison regression analysis
    • Tvete IF, Natvig B, Gåsemyr J, Meland N, Røine M, Klemp M. Comparing effects of biologic agents in treating patients with rheumatoid arthritis: a multiple treatment comparison regression analysis. PLoS ONE 10(9), e0137258 (2015).
    • (2015) PLoS ONE , vol.10 , Issue.9 , pp. e0137258
    • Tvete, I.F.1    Natvig, B.2    Gåsemyr, J.3    Meland, N.4    Røine, M.5    Klemp, M.6
  • 25
    • 80052977037 scopus 로고    scopus 로고
    • A mixed treatment comparison of the short-term efficacy of biologic disease modifying anti-rheumatic drugs in established rheumatoid arthritis
    • Turkstra E, Ng SK, Scuffham PA. A mixed treatment comparison of the short-term efficacy of biologic disease modifying anti-rheumatic drugs in established rheumatoid arthritis. Curr. Med. Res. Opin. 27(10), 1885-1897 (2011).
    • (2011) Curr. Med. Res. Opin. , vol.27 , Issue.10 , pp. 1885-1897
    • Turkstra, E.1    Ng, S.K.2    Scuffham, P.A.3
  • 26
    • 81355123266 scopus 로고    scopus 로고
    • A dose-response meta-analysis for quantifying relative efficacy of biologics in rheumatoid arthritis
    • Mandema JW, Salinger DH, Baumgartner SW, Gibbs MA. A dose-response meta-analysis for quantifying relative efficacy of biologics in rheumatoid arthritis. Clin. Pharmacol. Ther. 90(6), 828-835 (2011).
    • (2011) Clin. Pharmacol. Ther. , vol.90 , Issue.6 , pp. 828-835
    • Mandema, J.W.1    Salinger, D.H.2    Baumgartner, S.W.3    Gibbs, M.A.4
  • 27
    • 78650747686 scopus 로고    scopus 로고
    • Effectiveness of biologic therapies for rheumatoid arthritis: An indirect comparisons approach
    • Devine EB, Alfonso-Cristancho R, Sullivan SD. Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach. Pharmacotherapy 31(1), 39-51 (2011).
    • (2011) Pharmacotherapy , vol.31 , Issue.1 , pp. 39-51
    • Devine, E.B.1    Alfonso-Cristancho, R.2    Sullivan, S.D.3
  • 28
    • 84924978245 scopus 로고    scopus 로고
    • Randomized, doubleblind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy
    • Hobbs K, Deodhar A, Wang B et al. Randomized, doubleblind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy. Springerplus 4, 113 (2015).
    • (2015) Springerplus , vol.4 , pp. 113
    • Hobbs, K.1    Deodhar, A.2    Wang, B.3
  • 29
    • 84892449972 scopus 로고    scopus 로고
    • Remission in rheumatoid arthritis patients treated with etanercept monotherapy: Clinical practice and clinical trial experience
    • Cannon GW, Wang BC, Park GS, Koenig A, Collier DH, Keystone EC. Remission in rheumatoid arthritis patients treated with etanercept monotherapy: clinical practice and clinical trial experience. Clin. Exp. Rheumatol. 31(6), 919-925 (2013).
    • (2013) Clin. Exp. Rheumatol. , vol.31 , Issue.6 , pp. 919-925
    • Cannon, G.W.1    Wang, B.C.2    Park, G.S.3    Koenig, A.4    Collier, D.H.5    Keystone, E.C.6
  • 30
    • 84906725127 scopus 로고    scopus 로고
    • Older age at rheumatoid arthritis onset and comorbidities correlate with less health assessment questionnaire-disability index and clinical disease activity index response to etanercept in the RADIUS 2 registry
    • Martin WJ, Shim M, Paulus HE et al. Older age at rheumatoid arthritis onset and comorbidities correlate with less health assessment questionnaire-disability index and clinical disease activity index response to etanercept in the RADIUS 2 registry. J. Clin. Rheumatol. 20(6), 301-305 (2014).
    • (2014) J. Clin. Rheumatol. , vol.20 , Issue.6 , pp. 301-305
    • Martin, W.J.1    Shim, M.2    Paulus, H.E.3
  • 31
    • 84867809188 scopus 로고    scopus 로고
    • Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis
    • Canhão H, Rodrigues AM, Mourão AF et al. Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis. Rheumatology (Oxford) 51, 2020-2026 (2012).
    • (2012) Rheumatology (Oxford) , vol.51 , pp. 2020-2026
    • Canhão, H.1    Rodrigues, A.M.2    Mourão, A.F.3
  • 32
    • 84862563304 scopus 로고    scopus 로고
    • A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: Results from the US CORRONA registry
    • Greenberg JD, Reed G, Decktor D et al. A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registry. Ann. Rheum. Dis. 71, 1134-1142 (2012).
    • (2012) Ann. Rheum. Dis. , vol.71 , pp. 1134-1142
    • Greenberg, J.D.1    Reed, G.2    Decktor, D.3
  • 33
    • 84906791823 scopus 로고    scopus 로고
    • Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
    • Hirabara S, Takahashi N, Fukaya N et al. Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies. Clin. Rheumatol. 33(9), 1247-1254 (2014).
    • (2014) Clin. Rheumatol. , vol.33 , Issue.9 , pp. 1247-1254
    • Hirabara, S.1    Takahashi, N.2    Fukaya, N.3
  • 34
    • 38649098475 scopus 로고    scopus 로고
    • Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelveweek study
    • Burmester GR, Ferraccioli G, Flipo RM et al. Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelveweek study. Arthritis Rheum. 59(1), 32-41 (2008).
    • (2008) Arthritis Rheum. , vol.59 , Issue.1 , pp. 32-41
    • Burmester, G.R.1    Ferraccioli, G.2    Flipo, R.M.3
  • 35
    • 79953906254 scopus 로고    scopus 로고
    • Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up
    • Bartelds GM, Krieckaert CL, Nurmohamed MT et al. Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up. JAMA 305(14), 1460-1468 (2011).
    • (2011) JAMA , vol.305 , Issue.14 , pp. 1460-1468
    • Bartelds, G.M.1    Krieckaert, C.L.2    Nurmohamed, M.T.3
  • 36
    • 84882261762 scopus 로고    scopus 로고
    • Immunogenicity of monoclonal antibodies against tumor necrosis factor used in chronic immune-mediated Inflammatory conditions: Systematic review and meta-analysis
    • Maneiro JR, Salgado E, Gomez-Reino JJ. Immunogenicity of monoclonal antibodies against tumor necrosis factor used in chronic immune-mediated Inflammatory conditions: systematic review and meta-analysis. JAMA Intern Med. 173(15), 1416-1428 (2013).
    • (2013) JAMA Intern Med. , vol.173 , Issue.15 , pp. 1416-1428
    • Maneiro, J.R.1    Salgado, E.2    Gomez-Reino, J.J.3
  • 37
    • 33751416149 scopus 로고    scopus 로고
    • Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register
    • Hyrich KL, Watson KD, Silman AJ, Symmons DP. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 45(12), 1558-1565 (2006).
    • (2006) Rheumatology (Oxford) , vol.45 , Issue.12 , pp. 1558-1565
    • Hyrich, K.L.1    Watson, K.D.2    Silman, A.J.3    Symmons, D.P.4
  • 38
    • 43049162899 scopus 로고    scopus 로고
    • Treatment response to a second or third TNF-inhibitor in RA: Results from the South Swedish Arthritis Treatment Group Register
    • Karlsson JA, Kristensen LE, Kapetanovic MC, Gülfe A, Saxne T, Geborek P. Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register. Rheumatology (Oxford) 47(4), 507-513 (2008).
    • (2008) Rheumatology (Oxford) , vol.47 , Issue.4 , pp. 507-513
    • Karlsson, J.A.1    Kristensen, L.E.2    Kapetanovic, M.C.3    Gülfe, A.4    Saxne, T.5    Geborek, P.6
  • 39
    • 43049169008 scopus 로고    scopus 로고
    • Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: Results from the South Swedish Arthritis Treatment Group Register
    • Kristensen LE, Kapetanovic MC, Gülfe A, Söderlin M, Saxne T, Geborek P. Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register. Rheumatology 47(4), 495-499 (2008).
    • (2008) Rheumatology , vol.47 , Issue.4 , pp. 495-499
    • Kristensen, L.E.1    Kapetanovic, M.C.2    Gülfe, A.3    Söderlin, M.4    Saxne, T.5    Geborek, P.6
  • 40
    • 11144355274 scopus 로고    scopus 로고
    • Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed
    • van de Putte LBA, Atkins C, Malaise M et al. Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. Ann. Rheum. Dis. 63(5), 508-516 (2004)
    • (2004) Ann. Rheum. Dis. , vol.63 , Issue.5 , pp. 508-516
    • Van De-Putte, L.B.A.1    Atkins, C.2    Malaise, M.3
  • 41
    • 33947594031 scopus 로고    scopus 로고
    • The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis
    • Dore RK, Mathews S, Schechtman J et al. The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 25(1), 40-46 (2007).
    • (2007) Clin. Exp. Rheumatol. , vol.25 , Issue.1 , pp. 40-46
    • Dore, R.K.1    Mathews, S.2    Schechtman, J.3
  • 43
    • 0036169930 scopus 로고    scopus 로고
    • Guidelines for the management of rheumatoid arthritis: 2002 Update
    • American College Rheumatology Subcommittee On Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum. 46(2), 328-346 (2002).
    • (2002) Arthritis Rheum. , vol.46 , Issue.2 , pp. 328-346
  • 44
    • 84893772728 scopus 로고    scopus 로고
    • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
    • Smolen JS, Landewé R, Breedveld FC et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann. Rheum. Dis. 73(3), 492-509 (2013).
    • (2013) Ann. Rheum. Dis. , vol.73 , Issue.3 , pp. 492-509
    • Smolen, J.S.1    Landewé, R.2    Breedveld, F.C.3
  • 45
    • 84856315340 scopus 로고    scopus 로고
    • Secretaria de Atenção à Saúde. Portaria SAS/MS n° 996, de 30 de setembro de. Aprova o Protocolo Clínico e Diretrizes Terapêuticas da Artrite Reumatoide. Brasil (2015)
    • BRASIL. Ministério da Saúde. Secretaria de Atenção à Saúde. Portaria SAS/MS n° 996, de 30 de setembro de 2015. Aprova o Protocolo Clínico e Diretrizes Terapêuticas da Artrite Reumatoide. Brasil (2015). http://bvsms.saude.gov.br/bvs/saudelegis/sas
    • (2015) Ministério da Saúde
    • BRASIL1
  • 46
    • 84898627870 scopus 로고    scopus 로고
    • Review: Treat to target in rheumatoid arthritis: Fact, fiction, or hypothesis?
    • Solomon DH, Bitton A, Katz JN et al. Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis? Arthritis Rheumatol. 66(4), 775-782 (2014).
    • (2014) Arthritis Rheumatol. , vol.66 , Issue.4 , pp. 775-782
    • Solomon, D.H.1    Bitton, A.2    Katz, J.N.3
  • 47
    • 77950307115 scopus 로고    scopus 로고
    • Treating rheumatoid arthritis to target: Recommendations of an international task force
    • Smolen JS, Aletaha D, Bijlsma JW et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann. Rheum. Dis. 69, 631-637 (2010).
    • (2010) Ann. Rheum. Dis. , vol.69 , pp. 631-637
    • Smolen, J.S.1    Aletaha, D.2    Bijlsma, J.W.3
  • 48
    • 84870265734 scopus 로고    scopus 로고
    • Overview and analysis of treat-to-target trials in rheumatoid arthritis reporting on remission
    • Jurgens MS, Welsing PM, Jacobs JW. Overview and analysis of treat-to-target trials in rheumatoid arthritis reporting on remission. Clin. Exp. Rheumatol. 30(4, Suppl. 73), S56-S63 (2012).
    • (2012) Clin. Exp. Rheumatol. , vol.30 , Issue.4 , pp. S56-S63
    • Jurgens, M.S.1    Welsing, P.M.2    Jacobs, J.W.3
  • 49
    • 77950309959 scopus 로고    scopus 로고
    • Evidence for treating rheumatoid arthritis to target: Results of a systematic literature search
    • Schoels M, Knevel R, Aletaha D et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. Ann. Rheum. Dis. 69(4), 638-643 (2010).
    • (2010) Ann. Rheum. Dis. , vol.69 , Issue.4 , pp. 638-643
    • Schoels, M.1    Knevel, R.2    Aletaha, D.3
  • 50
    • 84889983501 scopus 로고    scopus 로고
    • Treating to the target of remission in early rheumatoid arthritis is cost-effective: Results of the DREAM registry
    • Vermeer M, Kievit W, Kuper HH et al. Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry. BMC Musculoskelet. Disord. 14, 350 (2013).
    • (2013) BMC Musculoskelet. Disord. , vol.14 , pp. 350
    • Vermeer, M.1    Kievit, W.2    Kuper, H.H.3
  • 51
    • 84903479861 scopus 로고    scopus 로고
    • Roles of nurse practitioners and physician assistants in rheumatology practices in the US
    • Solomon DH, Bitton A, Fraenkel L, Brown E, Tsao P, Katz JN. Roles of nurse practitioners and physician assistants in rheumatology practices in the US. Arthritis Care Res. 66(7), 1108-1113 (2014).
    • (2014) Arthritis Care Res. , vol.66 , Issue.7 , pp. 1108-1113
    • Solomon, D.H.1    Bitton, A.2    Fraenkel, L.3    Brown, E.4    Tsao, P.5    Katz, J.N.6
  • 52
    • 84055191578 scopus 로고    scopus 로고
    • Treat-to-target from the patient perspective
    • Gromnica-Ihle E, Rink M. Treat-to-target from the patient perspective. Z. Rheumatol. 70(8), 678-684 (2011).
    • (2011) Z. Rheumatol. , vol.70 , Issue.8 , pp. 678-684
    • Gromnica-Ihle, E.1    Rink, M.2
  • 53
    • 65849105320 scopus 로고    scopus 로고
    • Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritis
    • Greenberg JD, Harrold LR, Bentley MJ, Kremer J, Reed G, Strand V. Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritis. Rheumatology (Oxford) 48(6), 686-690 (2009).
    • (2009) Rheumatology (Oxford) , vol.48 , Issue.6 , pp. 686-690
    • Greenberg, J.D.1    Harrold, L.R.2    Bentley, M.J.3    Kremer, J.4    Reed, G.5    Strand, V.6
  • 54
    • 84992127542 scopus 로고    scopus 로고
    • The performance of the clinical disease activity index in patients with rheumatoid arthritis
    • Gunaydin R, Karatepe AG, Kaya T. The performance of the clinical disease activity index in patients with rheumatoid arthritis. Turk. Romatoloji. Dergisi. 21, 45-48 (2006).
    • (2006) Turk. Romatoloji. Dergisi. , vol.21 , pp. 45-48
    • Gunaydin, R.1    Karatepe, A.G.2    Kaya, T.3
  • 55
    • 80052428536 scopus 로고    scopus 로고
    • Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis
    • Klarenbeek NB, Koevoets R, van der Heijde DM et al. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis. Ann. Rheum. Dis. 70(10), 1815-1821 (2011).
    • (2011) Ann. Rheum. Dis. , vol.70 , Issue.10 , pp. 1815-1821
    • Klarenbeek, N.B.1    Koevoets, R.2    Van Der-Heijde, D.M.3
  • 56
    • 84880395911 scopus 로고    scopus 로고
    • Use of clinical disease activity index score for assessment of disease activity in rheumatoid arthritis patients: An Indian experience
    • Singh H, Kumar H, Handa R, Talapatra P, Ray S, Gupta V. Use of clinical disease activity index score for assessment of disease activity in rheumatoid arthritis patients: an Indian experience. Arthritis 2011, 146398 (2011)
    • (2011) Arthritis , vol.2011 , pp. 146398
    • Singh, H.1    Kumar, H.2    Handa, R.3    Talapatra, P.4    Ray, S.5    Gupta, V.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.